BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4157844)

  • 1. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological aspects of the fibrinolytic activity of Ateroid].
    Prino G; Mantovani M
    Minerva Med; 1969 Dec; 60(99 Suppl):5015-22. PubMed ID: 4188585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
    Prino G; Mantovani M; Butti A
    Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental animal studies on percutaneous modification of blood coagulation and fibrinolysis by a heparinoid containing gel].
    Giarola PA; Spreafico PL
    Arzneimittelforschung; 1970 Feb; 20(2):234-6. PubMed ID: 4191783
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anticoagulant and fibrinolytic activity of dextran sulphate (MDS) (author's transl)].
    Matsuoka M; Jinbo C; Watanabe T; Nonura J; Sakuragawa N
    Rinsho Ketsueki; 1973 Aug; 14(8):882-90. PubMed ID: 4128641
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basic principles anticoagulant therapy].
    Mammen EF
    Internist (Berl); 1969 Jan; 10(1):2-8. PubMed ID: 4190310
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact activation of prekallikrein and of fibrinolysis by heparinoids and heparin.
    Soulier JP; Gozin D
    Haematologia (Budap); 1980; 13(1-4):117-28. PubMed ID: 6166520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the mast cell in thrombolysis induced by heparin and a heparin-like substance SP54.
    FitzGerald DE
    Thromb Diath Haemorrh; 1969 Dec; 22(3):569-74. PubMed ID: 4192014
    [No Abstract]   [Full Text] [Related]  

  • 14. [The potentiation of the heparin effect by heparinoids. 4. On the action mechanism of heparinoids].
    Pulver R
    Arzneimittelforschung; 1965 Nov; 15(11):1320-3. PubMed ID: 4166203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of an extractive heparinoid on some blood coagulation indices].
    Guidi G; Lombardi V; Torsellini A
    Minerva Med; 1969 Dec; 60(99 Suppl):5034-8. PubMed ID: 4188587
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation.
    Kowalska MA; Zhao G; Zhai L; David G; Marcus S; Krishnaswamy S; Poncz M
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):120-6. PubMed ID: 24177324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in bleeding time in rats induced with local application of adenosine and its derivatives and other substances].
    Gibelli A; Giarola P; Spreafico PL
    Minerva Med; 1969 Dec; 60(98):4927-30. PubMed ID: 4187890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.